Because of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas.
Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists / Pagliarello, Calogero; Girardelli, Carlo Renè; Stanganelli, Ignazio. - In: DERMATOLOGY REPORTS. - ISSN 2036-7392. - 15:1(2023), p. 9534. [10.4081/dr.2022.9534]
Eruptive basal cell carcinoma and lenalidomide: rising awareness among dermatologists
Pagliarello, Calogero;Stanganelli, IgnazioSupervision
2023-01-01
Abstract
Because of its higher level of safety compared to its parent medicine, thalidomide, lenalidomide (L) is chosen for the treatment of multiple myeloma. We report a patient who, within a month of using L, developed more than 10 basal cell carcinomas.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
